Prognostic Impact of Bronchoalveolar Lavage Fluid Galactomannan and Aspergillus Culture Results on Survival in COVID-19 Intensive Care Unit Patients: a Post Hoc Analysis from the European Confederation of Medical Mycology (ECMM) COVID-19-Associated Pulmonary Aspergillosis Study

Critically ill patients with coronavirus disease 2019 (COVID-19) may develop COVID-19-associated pulmonary aspergillosis (CAPA), which impacts their chances of survival. Whether positive bronchoalveolar lavage fluid (BALF) mycological tests can be used as a survival proxy remains unknown. We conduct...

Descripción completa

Detalles Bibliográficos
Autores principales: Giacobbe, Daniele Roberto, Prattes, Juergen, Wauters, Joost, Dettori, Silvia, Signori, Alessio, Salmanton-García, Jon, Maertens, Johan, Bourgeois, Marc, Reynders, Marijke, Rutsaert, Lynn, Van Regenmortel, Niels, Lormans, Piet, Feys, Simon, Klimko, Nikolay, Shadrivova, Olga, Cornely, Oliver A., Rautemaa-Richardson, Riina, Koehler, Philipp, Lagrou, Katrien, Bassetti, Matteo, Hoenigl, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Mycology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020339/
https://www.ncbi.nlm.nih.gov/pubmed/35321555
http://dx.doi.org/10.1128/jcm.02298-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020339/
https://www.ncbi.nlm.nih.gov/pubmed/35321555
http://dx.doi.org/10.1128/jcm.02298-21

Ejemplares similares